BioCentury
ARTICLE | Clinical News

PRS-080: Phase I ongoing

June 15, 2015 7:00 AM UTC

Pieris completed dosing of 48 healthy volunteers in a double-blind, placebo-controlled, German Phase I trial evaluating single doses of 0.08-16 mg/kg IV PRS-080. Pieris said there were no dose-limitin...